Effects of statin on plaque stability and thrombogenicity in hypercholesterolemic patients with coronary artery disease
Authors:
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 88 (1) , 77-82
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In VitroCirculation, 2001
- Effects of HMG-CoA reductase inhibitor on hemostasisInternational Journal of Cardiology, 2000
- Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stabilityCardiovascular Research, 2000
- HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Vascular Effects of Estrogen and Vitamin E Therapies in Postmenopausal WomenCirculation, 1999
- Lipid Lowering Promotes Accumulation of Mature Smooth Muscle Cells Expressing Smooth Muscle Myosin Heavy Chain Isoforms in Rabbit AtheromaCirculation Research, 1998
- HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Lipid Lowering by Diet Reduces Matrix Metalloproteinase Activity and Increases Collagen Content of Rabbit AtheromaCirculation, 1998
- Vastatins Inhibit Tissue Factor in Cultured Human MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996